{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T11:50:19Z","timestamp":1791805819402,"version":"4.3.4"},"reference-count":22,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T00:00:00Z","timestamp":1708646400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","aaojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.ophtha.2024.01.032","type":"journal-article","created":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T16:36:19Z","timestamp":1706805379000},"page":"961-966","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Association of Cutaneous Keloids, Hypertrophic Scarring, and Fibrosis with Risk of Postoperative Proliferative Vitreoretinopathy"],"prefix":"10.1016","volume":"131","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7496-5118","authenticated-orcid":false,"given":"Danny A.","family":"Mammo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Wai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehsan","family":"Rahimy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn K.","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil K.","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prithvi","family":"Mruthyunjaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2024.01.032_bib1","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/IIO.0000000000000258","article-title":"Proliferative vitreoretinopathy: a review","volume":"59","author":"Idrees","year":"2019","journal-title":"Int Ophthalmol Clin"},{"key":"10.1016\/j.ophtha.2024.01.032_bib2","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0002-9394(98)00115-9","article-title":"Adjunctive daunorubicin in the treatment of proliferative vitreoretinopathy: results of a multicenter clinical trial. Daunomycin Study Group","volume":"126","author":"Wiedemann","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2024.01.032_bib3","doi-asserted-by":"crossref","first-page":"271","DOI":"10.4103\/2008-322X.188390","article-title":"Intravitreal injection of bevacizumab in primary vitrectomy to decrease the rate of retinal redetachment: a randomized pilot study","volume":"11","author":"Tousi","year":"2016","journal-title":"J\u00a0Ophthalmic Vis Res"},{"key":"10.1016\/j.ophtha.2024.01.032_bib4","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1080\/08820538.2021.1890791","article-title":"Molecular targets for proliferative vitreoretinopathy","volume":"36","author":"Wu","year":"2021","journal-title":"Semin Ophthalmol"},{"key":"10.1016\/j.ophtha.2024.01.032_bib5","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s00417-008-0829-0","article-title":"One-year results of a multicenter controlled clinical trial of triamcinolone in pars plana vitrectomy","volume":"246","author":"Yamakiri","year":"2008","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ophtha.2024.01.032_bib6","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.ophtha.2006.08.042","article-title":"Randomized controlled trial of combined 5-Fluorouracil and low-molecular-weight heparin in the management of unselected rhegmatogenous retinal detachments undergoing primary vitrectomy","volume":"114","author":"Wickham","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2024.01.032_bib7","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/j.ajpath.2013.01.052","article-title":"Ranibizumab is a potential prophylaxis for proliferative vitreoretinopathy, a nonangiogenic blinding disease","volume":"182","author":"Pennock","year":"2013","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ophtha.2024.01.032_bib8","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1001\/archopht.125.9.1161","article-title":"Safety and efficacy assessment of chimeric ribozyme to proliferating cell nuclear antigen to prevent recurrence of proliferative vitreoretinopathy","volume":"125","author":"Schiff","year":"2007","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2024.01.032_bib9","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.ophtha.2008.05.016","article-title":"Triamcinolone acetonide in silicone-filled eyes as adjunctive treatment for proliferative vitreoretinopathy: a randomized clinical trial","volume":"115","author":"Ahmadieh","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2024.01.032_bib10","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3928\/23258160-20220920-04","article-title":"Intravitreal methotrexate for the prevention and treatment of proliferative vitreoretinopathy in rhegmatogenous retinal detachment: a systematic review","volume":"53","author":"Balas","year":"2022","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"10.1016\/j.ophtha.2024.01.032_bib11","unstructured":"American Society of Retina Specialists Preferences and Trends (PAT) Survey. 2023. Accessed November 11, 2023."},{"key":"10.1016\/j.ophtha.2024.01.032_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0292698","article-title":"Risk factors for proliferative vitreoretinopathy after retinal detachment surgery: a systematic review and meta-analysis","volume":"18","author":"Xiang","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.ophtha.2024.01.032_bib13","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.ajo.2004.02.008","article-title":"Prevalence and risk factors for proliferative vitreoretinopathy in eyes with rhegmatogenous retinal detachment but no previous vitreoretinal surgery","volume":"137","author":"Tseng","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2024.01.032_bib14","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1001\/jamadermatol.2022.5607","article-title":"Comorbidities of keloid and hypertrophic scars among participants in UK biobank","volume":"159","author":"Ung","year":"2023","journal-title":"JAMA Dermatol"},{"issue":"Suppl 1","key":"10.1016\/j.ophtha.2024.01.032_bib15","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/DSS.0000000000000819","article-title":"Keloids and hypertrophic scars: pathophysiology, classification, and treatment","volume":"43","author":"Berman","year":"2017","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.ophtha.2024.01.032_bib16","first-page":"1","article-title":"Arthrofibrosis after total knee arthroplasty: patients with keloids at risk","volume":"22","author":"Flick","year":"2021","journal-title":"J\u00a0Orthop Traumatol"},{"key":"10.1016\/j.ophtha.2024.01.032_bib17","doi-asserted-by":"crossref","first-page":"377","DOI":"10.5152\/balkanmedj.2015.15707","article-title":"The relationship between proliferative scars and endothelial function in surgically revascularized patients","volume":"32","author":"Ziyrek","year":"2015","journal-title":"Balkan Med J"},{"key":"10.1016\/j.ophtha.2024.01.032_bib18","doi-asserted-by":"crossref","first-page":"e074","DOI":"10.1097\/JW9.0000000000000074","article-title":"A\u00a0retrospective study on the association of keloids with underlying health conditions in African-American Women","volume":"9","author":"Marella","year":"2023","journal-title":"Int J Womens Dermatol"},{"key":"10.1016\/j.ophtha.2024.01.032_bib19","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1055\/s-0041-1731461","article-title":"Current advances in hypertrophic scar and keloid management","volume":"35","author":"Barone","year":"2021","journal-title":"Semin Plast Surg"},{"key":"10.1016\/j.ophtha.2024.01.032_bib20","first-page":"1121","article-title":"XOMA 089, a novel anti-TGF-beta monoclonal antibody, inhibits experimental proliferative vitreoretinopathy in rabbits","volume":"55","author":"Mirza","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2024.01.032_bib21","doi-asserted-by":"crossref","DOI":"10.1177\/2050312120934839","article-title":"A\u00a0review of big data and medical research","volume":"8","author":"Mallappallil","year":"2020","journal-title":"SAGE Open Med"},{"key":"10.1016\/j.ophtha.2024.01.032_bib22","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/exd.13271","article-title":"Aberrant connective tissue differentiation towards cartilage and bone underlies human keloids in African Americans","volume":"26","author":"Fuentes-Duculan","year":"2017","journal-title":"Exp Dermatol"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642024000939?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642024000939?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T08:11:40Z","timestamp":1728547900000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642024000939"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":22,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S0161642024000939"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2024.01.032","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of Cutaneous Keloids, Hypertrophic Scarring, and Fibrosis with Risk of Postoperative Proliferative Vitreoretinopathy","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2024.01.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}